Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response

Yan Mei, Guangshuai Jia, Xiuying Liu et al.|Nature Cancer|2023

Cited by 219